BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23302879)

  • 21. Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles.
    McGinnes Cullen L; Schmidt MR; Morrison TG
    J Virol; 2019 May; 93(9):. PubMed ID: 30760576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Respiratory syncytial virus recombinant F protein (residues 255-278) induces a helper T cell type 1 immune response in mice.
    Singh SR; Dennis VA; Carter CL; Pillai SR; Moore EG
    Viral Immunol; 2007; 20(2):261-75. PubMed ID: 17603843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection.
    Eichinger KM; Kosanovich JL; Gidwani SV; Zomback A; Lipp MA; Perkins TN; Oury TD; Petrovsky N; Marshall CP; Yondola MA; Empey KM
    Front Immunol; 2020; 11():1673. PubMed ID: 32849580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B.
    Zhan X; Hurwitz JL; Krishnamurthy S; Takimoto T; Boyd K; Scroggs RA; Surman S; Portner A; Slobod KS
    Vaccine; 2007 Dec; 25(52):8782-93. PubMed ID: 18037543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective efficacy and immunogenicity of an adenoviral vector vaccine encoding the codon-optimized F protein of respiratory syncytial virus.
    Kohlmann R; Schwannecke S; Tippler B; Ternette N; Temchura VV; Tenbusch M; Uberla K; Grunwald T
    J Virol; 2009 Dec; 83(23):12601-10. PubMed ID: 19776123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonreplicating vaccines can protect african green monkeys from the memphis 37 strain of respiratory syncytial virus.
    Eyles JE; Johnson JE; Megati S; Roopchand V; Cockle PJ; Weeratna R; Makinen S; Brown TP; Lang S; Witko SE; Kotash CS; Li J; West K; Maldonado O; Falconer DJ; Lees C; Smith GJ; White P; Wright P; Loudon PT; Merson JR; Jansen KU; Sidhu MK
    J Infect Dis; 2013 Jul; 208(2):319-29. PubMed ID: 23596321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel influenza virus hemagglutinin-respiratory syncytial virus (RSV) fusion protein subunit vaccine against influenza and RSV.
    Turner TM; Jones LP; Tompkins SM; Tripp RA
    J Virol; 2013 Oct; 87(19):10792-804. PubMed ID: 23903841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant measles viruses expressing respiratory syncytial virus proteins induced virus-specific CTL responses in cotton rats.
    Yamaji Y; Nakayama T
    Vaccine; 2014 Jul; 32(35):4529-4536. PubMed ID: 24951869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8
    Lee JY; Chang J
    J Microbiol; 2017 Nov; 55(11):900-908. PubMed ID: 29076066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of recombinant measles vaccine expressing fusion protein of respiratory syncytial virus in cynomolgus monkeys.
    Sawada A; Yunomae K; Nakayama T
    Microbiol Immunol; 2018 Feb; 62(2):132-136. PubMed ID: 29194753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats.
    Binjawadagi B; Ma Y; Binjawadagi R; Brakel K; Harder O; Peeples M; Li J; Niewiesk S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.
    Lambert SL; Aslam S; Stillman E; MacPhail M; Nelson C; Ro B; Sweetwood R; Lei YM; Woo JC; Tang RS
    PLoS One; 2015; 10(3):e0119509. PubMed ID: 25793508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virus-specific CTL responses induced by an H-2K(d)-restricted, motif-negative 15-mer peptide from the fusion protein of respiratory syncytial virus.
    Jiang S; Borthwick NJ; Morrison P; Gao GF; Steward MW
    J Gen Virol; 2002 Feb; 83(Pt 2):429-438. PubMed ID: 11807236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pulmonary immune response of Balb/c mice vaccinated with the fusion protein of respiratory syncytial virus.
    Hancock GE; Hahn DJ; Speelman DJ; Hildreth SW; Pillai S; McQueen K
    Vaccine; 1994; 12(3):267-74. PubMed ID: 8165859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infection.
    Muralidharan A; Russell M; Larocque L; Gravel C; Li C; Chen W; Cyr T; Lavoie JR; Farnsworth A; Rosu-Myles M; Wang L; Li X
    Sci Rep; 2018 Nov; 8(1):16648. PubMed ID: 30413743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shifting immunodominance pattern of two cytotoxic T-lymphocyte epitopes in the F glycoprotein of the Long strain of respiratory syncytial virus.
    Johnstone C; de León P; Medina F; Melero JA; García-Barreno B; Val MD
    J Gen Virol; 2004 Nov; 85(Pt 11):3229-3238. PubMed ID: 15483236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the role of N-glycosylation sites in the respiratory syncytial virus fusion protein in virus replication, syncytium formation and antigenicity.
    Leemans A; Boeren M; Van der Gucht W; Martinet W; Caljon G; Maes L; Cos P; Delputte P
    Virus Res; 2019 Jun; 266():58-68. PubMed ID: 31004621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aged mice exhibit a severely diminished CD8 T cell response following respiratory syncytial virus infection.
    Fulton RB; Weiss KA; Pewe LL; Harty JT; Varga SM
    J Virol; 2013 Dec; 87(23):12694-700. PubMed ID: 24049171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inferior immunogenicity and efficacy of respiratory syncytial virus fusion protein-based subunit vaccine candidates in aged versus young mice.
    Cayatte C; Snell Bennett A; Rajani GM; Hostetler L; Maynard SK; Lazzaro M; McTamney P; Ren K; O'Day T; McCarthy MP; Schneider-Ohrum K
    PLoS One; 2017; 12(11):e0188708. PubMed ID: 29182682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection.
    Yu JR; Kim S; Lee JB; Chang J
    J Virol; 2008 Mar; 82(5):2350-7. PubMed ID: 18094185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.